Towards natural mimetics of metformin and rapamycin.

Volume: 9, Issue: 11, Pages: 2245 - 2268
Published: Nov 15, 2017
Abstract
Aging is now at the forefront of major challenges faced globally, creating an immediate need for safe, widescale interventions to reduce the burden of chronic disease and extend human healthspan. Metformin and rapamycin are two FDA-approved mTOR inhibitors proposed for this purpose, exhibiting significant anti-cancer and anti-aging properties beyond their current clinical applications. However, each faces issues with approval for off-label,...
Paper Details
Title
Towards natural mimetics of metformin and rapamycin.
Published Date
Nov 15, 2017
Journal
Volume
9
Issue
11
Pages
2245 - 2268
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.